CL
AMRI

CSS LLC’s Albany Molecular Research Inc AMRI Stock Holding History

CSS LLC’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,000
Closed -$140K – 735
2017
Q1 		$140K Buy
+10,000
New +$164K 0.01% 527
2015
Q4 		– Sell
-2,500
Closed -$44K – 811
2015
Q3 		$44K Buy
+2,500
New +$50.9K ﹤0.01% 705

Other funds holding AMRI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

CSS LLC's AMRI Position: Q4 2016 in Review

CSS LLC sold out of Albany Molecular Research Inc (AMRI) in Q4 2016, closing a stake of 18,200 shares — an estimated $300K sold.

CSS LLC first reported a position in AMRI in Q1 2014 and held it in 11 quarters. The position peaked at $300K in Q3 2016. 133 funds tracked by Wall St. Rank hold AMRI as of Q4 2016.

  • CSS LLC reported no remaining Albany Molecular Research Inc position as of Q4 2016 after selling out during the quarter.
  • CSS LLC sold 18,200 Albany Molecular Research Inc shares in Q4 2016, an estimated $300K.
  • CSS LLC first reported a position in Albany Molecular Research Inc in Q1 2014 and held it in 11 quarters.
  • CSS LLC's Albany Molecular Research Inc position peaked at $300K in Q3 2016.
  • 133 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2016.

Based on CSS LLC's 13F filing for Q4 2016, filed 14 Feb 2017.